
Dr. Juliana Bogado explains how to differentiate facts from misinformation and clarifies doubts about the safe and responsible use of cannabidiol in Brazil

Brazilian researchers analyze the benefits of cannabidiol for athletes and the regulatory challenges that put careers at risk due to contamination by prohibited substances

Clinical research suggests improvement in pain perception and emotional symptoms

New research paves the way for the treatment of alcohol use disorder

Former president's post about the benefits of CBD derived from hemp for seniors stirred up the cannabis market in the US

Research investigates if cannabidiol (CBD) can reduce puppies' stress during car travels, pointing out promising results and paving the way for new studies in veterinary medicine

Expert emphasizes that with medical supervision and individual attention, the use of cannabidiol can be done safely for liver health

Study reveals that the rare cannabinoid has remarkable antioxidant properties and anti-inflammatory action; expert warns of the need for more studies

New service at Case will assist individuals with aggressive behavior in ASD, using cannabidiol for the first time and registered at Nate

PL 569/2021, which provides for the supply of cannabidiol-based medications in public and affiliated units, has a favorable opinion in the Health Committee

According to Filipe Campos, from Close-Up International, the market could expand even further with rule updates and greater medical adherence

Neurosurgeon explains how cannabidiol acts in the brains of patients with pharmacoresistant epilepsy in a special episode of the Deusa Cast

Understand how cannabidiolic acid acts before being heated and what benefits it offers

Research identifies cannabidiol (CBD) as a promising and sustainable alternative for controlling viral diseases in aquaculture, replacing the use of antibiotics

Anvisa authorizations for importing cannabidiol in São Paulo increased by 6.2% between January and July 2025, consolidating the state as a leader in requests and reflecting the expanded access through the SUS

Brazilian study reveals that cannabidiol can relieve pain, seizures, and inflammations in dogs, opening new perspectives for veterinary medicine

Pharmaceutical company Ephar has obtained registration for its Cannabidiol in two concentrations, 50 mg/mL and 100 mg/mL, which will be marketed in a low THC content drop solution

Still in the study phase, cannabidiol shows potential to relieve symptoms such as pain, swelling, and insomnia related to varicose veins

City Hall evaluates the implementation of a public policy to provide cannabidiol-based medications in the municipality

Report shows that nearly 400 million people worldwide have alcohol-related disorders. Scientists are investigating cannabidiol (CBD) as a promising tool in combating addiction